1 Quintanilla-Martinez L,Ridaura C,Nagl F,et al.Hydroa vacciniforme-like lymphoma:a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma[J].Blood,2013,122(18):3101-3110.
2 Park S,Ko YH.Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders [J].Dermatol,2014,41(1):29-39.
3 Wang Q,Liu H,Zhang X,et al.High dose of mother′s lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood[J].Blood,2010,116(26):5941-5947.
4 Yang YQ,Fan L,Wang L,et al.Systemic lymphoma arising from hydroa vacciniforme-like lymphoma:report of two cases with review of literature[J].Int J Clin Exp Pathol,2014,7(9):6403-6408.
5 Lim MS,De Leval L,Quintanilla-Martinez L.Commentary on the 2008 WHO classification of mature T-and NK-cell neoplasms[J].Hematopathology,2009,2(2):65-73.
6 李海英,王际立,高铁铮,等.种痘水疱病样皮肤T细胞淋巴瘤1例报道及文献复习[J].中国当代儿科杂志,2009,11(7):596-598.
7 Park S,Kim K,Kim WS,et al.Systemic EBV+ T-cell lymphoma in elderly patients:comparison with children and young adult patients[J].Vichow Arech,2008,453(2):155-163.
8 Bollard CM,Gottschalk S,Leen AM,et al.Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T lymphocyte transfer[J].Blood,2007,110(8):2838-2845.
9 El-Mallawany NK,Geller L,Bollard CM,et al.Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+ related allogeneic hematopoietic SCT followed by donorderived EBV-specific cytotoxic T-lymphocyte immunotherapy[J].Bone Marrow Transplant,2011,46(5):759-761. |
